Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr 15:15:1490621.
doi: 10.3389/fonc.2025.1490621. eCollection 2025.

Meta-analysis of medical cannabis outcomes and associations with cancer

Affiliations

Meta-analysis of medical cannabis outcomes and associations with cancer

Ryan D Castle et al. Front Oncol. .

Abstract

Background: Growing bodies of evidence suggest that cannabis may play a significant role in both oncological palliative care and as a direct anticarcinogenic agent, but classification as a Schedule I substance has complicated research into its therapeutic potential, leaving the state of research scattered and heterogeneous. This meta-analysis was conducted to determine the scientific consensus on medical cannabis' viability in cancer treatment.

Objective: The aim of this meta-analysis was to systematically assess the existing literature on medical cannabis, focusing on its therapeutic potential, safety profiles, and role in cancer treatment.

Methods: This study synthesized data from over 10,000 peer-reviewed research papers, encompassing 39,767 data points related to cannabis and various health outcomes. Using sentiment analysis, the study identified correlations between cannabis use and supported, not supported, and unclear sentiments across multiple categories, including cancer dynamics, health metrics, and cancer treatments. A sensitivity analysis was conducted to validate the reliability of the findings.

Results: The meta-analysis revealed a significant consensus supporting the use of medical cannabis in the categories of health metrics, cancer treatments, and cancer dynamics. The aggregated correlation strength of cannabis across all cancer topics indicates that support for medical cannabis is 31.38× stronger than opposition to it. The analysis highlighted the anti-inflammatory potential of cannabis, its use in managing cancer-related symptoms such as pain, nausea, and appetite loss, and explored the consensus on its use as an anticarcinogenic agent.

Discussion: The findings indicate a strong and growing consensus within the scientific community regarding the therapeutic benefits of cannabis, particularly in the context of cancer. The consistent correlation strengths for cannabis as both a palliative adjunct and a potential anticarcinogenic agent redefine the consensus around cannabis as a medical intervention.

Conclusion: The consistency of positive sentiments across a wide range of studies suggests that cannabis should be re-evaluated within the medical community as a treatment option. The findings have implications for public health research, clinical practice, and discussions surrounding the legal status of medical cannabis. These results suggest a need for further research to explore the full therapeutic potential of cannabis and address knowledge gaps.

Keywords: cancer; cannabis; data analytics; medical Marijuana; meta-analysis; oncology; outcomes; whole health.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Inclusion process for meta-analysis. Initial body of articles identified through PubMed and MeSH, followed by eligibility filter by formatting and copyright accessible permissions, resulting in a final screening that eliminated duplicates and irrelevant articles, resulting in 10641 relevant, unique studies.
Figure 2
Figure 2
Proportion of keywords allocated to different sentiments as keyword occurrences.
Figure 3
Figure 3
Correlation between individual keywords relating to cannabinoid types and the keyword occurrence association with supported, not supported, and unclear sentiments. All associations meet minimum p-value and r scores for inclusion in refined data.
Figure 4
Figure 4
Correlation between all topics and the keyword occurrence association with supported, not supported, and unclear sentiments. All associations meet minimum p-value and r scores for inclusion in refined data.
Figure 5
Figure 5
Correlation between all topics and the dominant instance association with supported, not supported, and unclear sentiments. All associations meet minimum p-value and r scores for inclusion in refined data.
Figure 6
Figure 6
Correlation between topics relating to cannabis and health metrics and the keyword occurrence association with supported, not supported, and unclear sentiments. Horizontal axis measures Pearson’s r strength. All associations meet minimum p-value and r scores for inclusion in refined data.
Figure 7
Figure 7
Correlation between topics relating to cannabis and health metrics and the dominant instance association with supported, not supported, and unclear sentiments. Horizontal axis measures Pearson’s r strength. All associations meet minimum p-value and r scores for inclusion in refined data.
Figure 8
Figure 8
Correlation between individual keywords relating to cannabis and health metrics and the keyword occurrence association with supported, not supported, and unclear sentiments. Horizontal axis measures Pearson’s r strength. All associations meet minimum p-value and r scores for inclusion in refined data.
Figure 9
Figure 9
Correlation between topics relating to cannabis and cancer treatments and the keyword occurrence association with supported, not supported, and unclear sentiments. Horizontal axis measures Pearson’s r strength. All associations meet minimum p-value and r scores for inclusion in refined data.
Figure 10
Figure 10
Correlation between topics relating to cannabis and cancer treatments and the dominant instance association with supported, not supported, and unclear sentiments. Horizontal axis measures Pearson’s r strength. All associations meet minimum p-value and r scores for inclusion in refined data.
Figure 11
Figure 11
Correlation between individual keywords relating to cannabis and cancer treatments and the keyword occurrence association with supported, not supported, and unclear sentiments. Horizontal axis measures Pearson’s r strength. All associations meet minimum p-value and r scores for inclusion in refined data.
Figure 12
Figure 12
Correlation between topics relating to cannabis and cancer dynamics and the keyword occurrence association with supported, not supported, and unclear sentiments. Horizontal axis measures Pearson’s r strength. All associations meet minimum p-value and r scores for inclusion in refined data.
Figure 13
Figure 13
Correlation between topics relating to cannabis and cancer dynamics and the dominant instance association with supported, not supported, and unclear sentiments. Horizontal axis measures Pearson’s r strength. All associations meet minimum p-value and r scores for inclusion in refined data.
Figure 14
Figure 14
Correlation between individual keywords relating to cannabis and cancer dynamics and the keyword occurrence association with supported, not supported, and unclear sentiments. Horizontal axis measures Pearson’s r strength. All associations meet minimum p-value and r scores for inclusion in refined data.

Similar articles

References

    1. Cannabis in Medical Practice: A Legal, Historical and Pharmacological Overview of the Therapeutic Use of Marijuana. Mathre ML. (Ed.), United Kingdom: McFarland, Incorporated, Publishers; (1997).
    1. O’Shaughnessy WB. On the Preparations of the Indian Hemp, or Gunjah: Cannabis Indica Their Effects on the Animal System in Health, and their Utility in the Treatment of Tetanus and other Convulsive Diseases. Prov Med J Retrosp Med Sci. (1843) 5:363–9. - PMC - PubMed
    1. Gaoni Y, Mechoulam R. Isolation, structure, and partial synthesis of an active constituent of hashish. J Am Chem Soc. (1964) 86(8):1646–7. doi: 10.1021/j01062046 - DOI
    1. Cooper ZD, Abrams DI, Gust S, Salicrup A, Throckmorton DC. Challenges for clinical cannabis and cannabinoid research in the United States. J Natl Cancer Inst Monogr. (2021) 2021:114–22. doi: 10.1093/jncimonographs/lgab009 - DOI - PMC - PubMed
    1. Campbell AW. The Medical Marijuana Catch-22: how the federal monopoly on marijuana research unfairly handicaps the rescheduling movement. Am J Law Med. (2015) 41:190–209. doi: 10.1177/0098858815591513 - DOI - PubMed

Publication types

LinkOut - more resources